FGL1 and metabolic dysfunction-associated steatotic liver disease: FGL1 silencing or overexpression consequently alleviated or worsened NAFLD as evinced by indices such as serum transaminase, triglyceride levels, inflammatory markers and lipid synthesis-related genes (sterol regulatory element-binding protein-1, fatty acid synthase and acetyl-CoA carboxylase-1) 22.